BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37744571)

  • 1. Perspectives of patients with advanced or metastatic non-small cell lung cancer on symptoms, impacts on daily activities, and thresholds for meaningful change: a qualitative research study.
    Cardellino A; Shah M; Hanlon J; Kelly K; Martin A; de Climens AR; Taiyari S; Stojadinovic A
    Front Psychol; 2023; 14():1217793. PubMed ID: 37744571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' and clinicians' perspectives on item importance, scoring, and clinically meaningful differences for the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS).
    Kitchen H; Seitz C; Trigg A; Aldhouse N; Willgoss T; Schmitz H; Gater A; Gerlinger C; Haberland C
    Health Qual Life Outcomes; 2021 Jan; 19(1):7. PubMed ID: 33407560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren's.
    Cooper C; Wratten S; Williams-Hall R; Bookman AAM; Ndife B; Hueber W; Goswami P
    Rheumatol Ther; 2022 Dec; 9(6):1499-1515. PubMed ID: 36114443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients.
    Schmalz O; Jacob C; Ammann J; Liss B; Iivanainen S; Kammermann M; Koivunen J; Klein A; Popescu RA
    J Med Internet Res; 2020 Dec; 22(12):e18655. PubMed ID: 33346738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the PRUCISION Instruments in Pediatric Patients with Progressive Familial Intrahepatic Cholestasis.
    Gwaltney C; Ivanescu C; Karlsson L; Warholic N; Kjems L; Horn P
    Adv Ther; 2022 Nov; 39(11):5105-5125. PubMed ID: 36066745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Do Patients With Non-Small-Cell Lung Cancer Experience? Content Domain for the MD Anderson Symptom Inventory for Lung Cancer.
    Whisenant MS; Williams LA; Garcia Gonzalez A; Mendoza T; Shi Q; Cleeland C; Zhang J; Heymach J; Simon G
    JCO Oncol Pract; 2020 Oct; 16(10):e1151-e1160. PubMed ID: 32539654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Impact of Fatigue in Progressive Multiple Sclerosis: A Mixed-Methods Analysis.
    Penner IK; McDougall F; Brown TM; Slota C; Doward L; Julian L; Belachew S; Miller D
    Mult Scler Relat Disord; 2020 Aug; 43():102207. PubMed ID: 32505026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the patient experience and treatment benefits in patients with non-small-cell lung cancer with brain metastasis.
    Cella D; Wen PY; Ervin C; Vallow S; Gilloteau I; DeMuro C; Mordin M; Chassot Agostinho A; Dine J
    Cancer Med; 2023 Jun; 12(12):13637-13648. PubMed ID: 37306665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): Measurement Properties and Estimated Clinically Meaningful Thresholds From a Phase 3 Study.
    Williams P; Burke T; Norquist JM; Daskalopoulou C; Speck RM; Samkari A; Eremenco S; Coons SJ
    JTO Clin Res Rep; 2022 Apr; 3(4):100298. PubMed ID: 35400081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient's Perspective: A Qualitative Study.
    Jackson K; Parthan A; Lauher-Charest M; Broderick L; Law N; Barnett C
    Neurol Ther; 2023 Feb; 12(1):107-128. PubMed ID: 36322146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
    McCarrier KP; Atkinson TM; DeBusk KP; Liepa AM; Scanlon M; Coons SJ;
    Clin Ther; 2016 Apr; 38(4):794-810. PubMed ID: 27041408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric Validation and Meaningful Change Thresholds of the New Nasal Polyposis Symptom Diary.
    Shih VH; Slagle AF; Ivanescu C; Flore G; Meyers O; Kreindler J; Martin UJ; Werkström V
    Ann Otol Rhinol Laryngol; 2023 Dec; 132(12):1638-1648. PubMed ID: 37271980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative interviews to improve patient-reported outcome measures in late-onset Pompe disease: the patient perspective.
    Hamed A; An Haack K; Gwaltney C; Baranowski E; Stewart A; Krupnick R; Tyler M; Sparks S; Paty J
    Orphanet J Rare Dis; 2021 Oct; 16(1):428. PubMed ID: 34641935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Experience in Early-Stage Parkinson's Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment.
    Morel T; Cleanthous S; Andrejack J; Barker RA; Blavat G; Brooks W; Burns P; Cano S; Gallagher C; Gosden L; Siu C; Slagle AF; Trenam K; Boroojerdi B; Ratcliffe N; Schroeder K
    Neurol Ther; 2022 Sep; 11(3):1319-1340. PubMed ID: 35778541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms and Impacts in Metastatic Castration-Resistant Prostate Cancer: Qualitative Findings from Patient and Physician Interviews.
    Holmstrom S; Naidoo S; Turnbull J; Hawryluk E; Paty J; Morlock R
    Patient; 2019 Feb; 12(1):57-67. PubMed ID: 30519830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Small Cell Lung Cancer Symptom Assessment Questionnaire: Psychometric Performance and Regulatory Qualification of a Novel Patient-Reported Symptom Measure.
    Bushnell DM; Atkinson TM; McCarrier KP; Liepa AM; DeBusk KP; Coons SJ;
    Curr Ther Res Clin Exp; 2021; 95():100642. PubMed ID: 34567289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meaningful Within-Patient Change on the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ): Analysis of Phase III Clinical Trial Data of Daridorexant.
    Phillips-Beyer A; Kawata AK; Kleinman L; Kinter DS
    Pharmaceut Med; 2023 Jul; 37(4):291-303. PubMed ID: 37286927
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.